SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-033287
Filing Date
2020-02-12
Accepted
2020-02-12 16:32:33
Documents
1
Group Members
JULIET TAMMENOMS BAKKERLONGITUDE VENTURE PARTNERS II, L.P.PATRICK G. ENRIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d885121dsc13ga.htm SC 13G/A 77465
  Complete submission text file 0001193125-20-033287.txt   79209
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89113 | Film No.: 20604653
SIC: 2834 Pharmaceutical Preparations

Mailing Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025
Business Address 800 EL CAMINO REAL SUITE 220 MENLO PARK CA 94025 650-854-5700
Longitude Capital Partners II, LLC (Filed by) CIK: 0001647491 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A